Intesa Sanpaolo (OTCMKTS:ISNPY) Rating Lowered to “Strong Sell” at Zacks Research
by Danessa Lincoln · The Markets DailyIntesa Sanpaolo (OTCMKTS:ISNPY – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Monday, Zacks reports.
ISNPY has been the subject of a number of other reports. Citigroup initiated coverage on shares of Intesa Sanpaolo in a research report on Friday, November 6th. They issued a “strong-buy” rating for the company. Royal Bank Of Canada restated an “outperform” rating on shares of Intesa Sanpaolo in a research report on Thursday, July 30th. Two analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intesa Sanpaolo currently has a consensus rating of “Moderate Buy”.
Read Our Latest Report on Intesa Sanpaolo
Intesa Sanpaolo Stock Performance
Shares of OTCMKTS:ISNPY opened at $43.20 on Monday. The stock has a 50 day moving average of $43.44 and a 200 day moving average of $41.91. The company has a market cap of $127.31 billion, a PE ratio of 11.11 and a beta of 0.85. Intesa Sanpaolo has a 12-month low of $34.06 and a 12-month high of $48.42.
About Intesa Sanpaolo
Intesa Sanpaolo is an Italian banking group serving individuals, businesses and institutional clients. Its services include retail and commercial banking, lending, payments, investment banking, wealth management, asset management and insurance. The group was formed in 2007 through the merger of Banca Intesa and Sanpaolo IMI. It is headquartered in Italy and has an international presence, including operations in Central and Eastern Europe and other markets. Intesa Sanpaolo’s activities span everyday banking and financing as well as investment and advisory services, delivered through its banking network and specialist businesses.
Recommended Stories
- Five stocks we like better than Intesa Sanpaolo
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]